Ghaid Asfour
Biographic Data
| ID | 10011551 |
|---|---|
| NAME | Ghaid Asfour |
| GIVEN NAMES | Ghaid |
| FAMILY NAME | Asfour |
| SIGNATURE | ASFOUR G |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Vaccine efficacy against Sars-CoV-2 for Pfizer BioNTech, Moderna, and AstraZeneca vaccines
The purpose of this systematic review was to report on the vaccine efficacy (VE) of three SARS-CoV-2 vaccines approved by Health Canada: Pfizer BioNTech, Moderna, and AstraZeneca. Four databases were searched for primary publications on population-level VE. Ninety-two publications matched the inclusion criteria, and the extracted data were separated by vaccine type: mRNA vaccines (Pfizer and Moderna) and the AstraZeneca vaccine. The median VE for…
No prominent works on this page.
Vaccine efficacy against Sars-CoV-2 for Pfizer BioNTech, Moderna, and AstraZeneca vaccines
The purpose of this systematic review was to report on the vaccine efficacy (VE) of three SARS-CoV-2 vaccines approved by Health Canada: Pfizer BioNTech, Moderna, and AstraZeneca. Four databases were searched for primary publications on population-level VE. Ninety-two publications matched the inclusion criteria, and the extracted data were separated by vaccine type: mRNA vaccines (Pfizer and Moderna) and the AstraZeneca vaccine. The median VE for…